Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Registry Hub
Irrigation Solution/Discontinued

PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER

PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER

Clinical safety rating

caution

Comprehensive clinical and safety monograph for PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER (PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER).


Mechanism of Action

Replacement of extracellular fluid and electrolytes; provides buffering capacity via bicarbonate precursor (acetate) and maintains physiological pH.

What the body does with it

MetabolismAcetate is metabolized primarily in the liver and muscles to bicarbonate.
ExcretionPrimarily renal; >95% of infused ions (sodium, chloride, lactate, calcium, magnesium) are excreted unchanged in urine. Biliary/fecal elimination negligible (<1%).
Half-lifeNot applicable; components follow first-order kinetics with rapid redistribution. Lactate half-life ~15-30 minutes (hepatic metabolism).
Protein bindingNegligible (<1%); ions are free in plasma (no significant protein binding).
Volume of Distribution0.4 L/kg; distributes mainly in extracellular fluid (ECF).
Bioavailability100% (intravenous); not absorbed orally.
Onset of ActionImmediate upon intravenous infusion; correction of hypovolemia occurs within minutes.
Duration of ActionShort; effects last ~1-2 hours post-infusion due to rapid renal excretion and redistribution.
Molecular WeightN/A (mixture of ions: Na=23, Cl=35.5, Ca=40.1, Mg=24.3, etc.)

Classification & Brands

Dosing & administration

Intravenous infusion, rate adjusted based on clinical status and electrolyte needs; typical adult dose is 500-1000 mL over 1-2 hours.

Dosage formSOLUTION
Renal impairmentContraindicated in oliguric or anuric renal failure; in GFR <30 mL/min, avoid use or monitor electrolytes closely; no specific GFR-based dose adjustment.
Liver impairmentNo specific Child-Pugh based adjustments; use with caution in hepatic impairment due to risk of fluid overload.
Pediatric useWeight-based dosing: 5-10 mL/kg intravenous infusion over 1-2 hours, not to exceed 30 mL/kg/day.
Geriatric useUse with caution due to increased risk of fluid overload and electrolyte imbalance; adjust rate and volume based on renal function and comorbidities, typical initial dose 500 mL over 2-3 hours.

Use during pregnancy

1st trimesterPhysiosol pH 7.4 is a balanced electrolyte solution; no known teratogenic effects. Use only if clearly needed.
2nd trimesterGenerally safe; monitor for electrolyte imbalances and fluid overload.
3rd trimesterSafe when used appropriately; caution near term due to possible fluid shifts.

Clinical note

Comprehensive clinical and safety monograph for PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER (PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER).

Placental transferComponents (sodium, chloride, calcium, magnesium, etc.) cross placenta via normal physiological mechanisms; no specific studies for this product.
BreastfeedingPhysiosol pH 7.4 components are normal plasma constituents; no anticipated harm to infant during breastfeeding. Administer as needed.
Lactation RatingL1
Teratogenic RiskPhysiosol pH 7.4 (balanced electrolyte solution) is considered low risk for teratogenicity. There are no known fetal risks associated with its use in any trimester, as it is a physiological solution. However, large volumes or rapid administration could theoretically cause maternal electrolyte imbalances, which may indirectly affect the fetus.
Fetal MonitoringMonitor maternal serum electrolytes, fluid balance, and renal function during prolonged or high-volume administration. In pregnancy, monitor for signs of fluid overload or electrolyte disturbances due to increased plasma volume.
Fertility EffectsNo known adverse effects on fertility. The solution contains standard electrolytes and water, which are not expected to impair reproductive function.

Warnings & precautions

■ FDA Black Box Warning

None.

Side Effect Profile

Serious Effects

Absolute Contraindications

Hypersensitivity to any componentSevere hypercalcemiaSevere hypermagnesemiaSevere hypernatremia

Clinical Precautions

PrecautionsUse with caution in patients with severe renal impairment, heart failure, or conditions associated with sodium retention, Monitor serum electrolytes, fluid balance, and acid-base status during prolonged administration, Risk of volume overload in patients with compromised cardiac or renal function, Contains aluminum; may be toxic with prolonged use in patients with renal impairment
Food/DietaryNo food interactions are relevant as Physiosol pH 7.4 is not ingested. It is used exclusively for topical irrigation during medical procedures.

Clinical Tips & Counseling

Clinical PearlsPhysiosol pH 7.4 is a balanced crystalloid solution used for irrigation, not for systemic administration. In the operating room, it is preferred for peritoneal lavage due to its neutral pH, which minimizes tissue irritation. Do not use for intravenous infusion; verify labeling to avoid confusion with IV solutions. Warm to body temperature before use to prevent hypothermia during large-volume irrigation.
Patient AdviceThis solution is used to rinse body cavities during surgery, not for intravenous use. · You may feel a cooling sensation during irrigation; this is normal. · Report any signs of infection at the surgical site, such as redness, swelling, or discharge. · Do not attempt to use this solution at home; it is for hospital use only.

PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER Interactions

Loading safety data…

This overview is compiled from peer-reviewed clinical sources and FDA labeling. It's here to support — not replace — clinical judgment. Always verify dosing against your institution's current protocols before prescribing.

On this page

Mechanism of ActionDosing & administrationUse during pregnancyWarnings & precautionsDrug interactions

Compare with

ACETIC ACID 0.25% IN PLASTIC CONTAINERPHOXILLUM B22K 4/0 IN PLASTIC CONTAINERPHOXILLUM BK 4/2.5 IN PLASTIC CONTAINERPHYSIOLYTE IN PLASTIC CONTAINERPHYSIOSOL IN PLASTIC CONTAINER

External sources

DailyMed (NIH) PubMed OpenFDA